ClinicalTrials.gov
ClinicalTrials.gov Menu
Open or close the search fields display
1 Study found for: GSK525762 in subjects with relapsed, refractory hematologic malignancies

Terms and Synonyms Searched:

Terms Search Results* Entire Database**
Synonyms
GSK525762 in subjects with relapsed, refractory hematologic malignancies 1 studies 1 studies
refractory hematologic malignancies 1 studies 68 studies
Refractory Hematologic Cancer -- 13 studies
malignancies 1 studies 72,005 studies
Tumor 1 studies 34,353 studies
Oncology 1 studies 12,461 studies
Cancer 1 studies 57,343 studies
Malignant Growth -- 2 studies
Neoplasia -- 840 studies
Neoplasm -- 56,465 studies
Neoplastic Disease -- 63 studies
neoplastic growth -- 2 studies
neoplastic syndrome -- 538 studies
hematologic 1 studies 17,354 studies
hematology 1 studies 8,008 studies
Haematologic -- 40 studies
refractory 1 studies 8,973 studies
Intractable -- 303 studies
Unresponsive -- 271 studies
relapsed 1 studies 12,147 studies
Relapse -- 7,689 studies
relapsing -- 1,353 studies
subjects 1 studies 74,300 studies
Study Participant -- 2,937 studies
GSK525762 1 studies 7 studies

   
-- No studies found
* Number of studies in the search results containing the term or synonym
** Number of studies in the entire database containing the term or synonym